BUY Divi's Laboratories Limited — Rachna Vaidya
byRachna VaidyaHorizon: BTST2 Jun 2026, 11:30 pm ISTvia CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Divi's FY26 net profit rises 17% to ₹2,568 crore
NewsGoogle News·30 May · 4d ago
1 advisor has an active swing BUY call on this stock, issued in the last 14 days
Advisor consensus · adjacent horizon·25 May · 1w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Divi's Laboratories
- BUY — Chandan Taparia, Motilal Oswal13 Nov 2026 · ~2 weeks · target ₹12,400 · Active
- BUY — Nuvama Wealth9 Nov 2026 · ~1 year · target ₹12,000 · Active
- BUY — Jefferies India9 Nov 2026 · ~1 year · target ₹12,550 · Active
- BUY — Morgan Stanley9 Nov 2026 · ~1 year · target ₹11,359 · Target hit
- SELL — Elara Capital9 Nov 2026 · ~1 year · target ₹6,539 · Active
More from Rachna Vaidya
- BUY HDFC Asset Management Company11 Nov 2026 · Same day · target ₹2,725 · Expired
- BUY BSE11 Nov 2026 · ~2 weeks · target ₹3,950 · Target hit
- BUY Havells India11 Nov 2026 · ~2 weeks · target ₹1,170 · Target hit
- BUY Havells India8 Nov 2026 · ~2 weeks · target ₹1,200 · Active
- BUY Multi Commodity Exchange of India6 Nov 2026 · Same day · target ₹3,420 · Target hit

